According to this study, the global siRNA Drugs market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of siRNA Drugs market by product type, application, key players and key regions and countries.

Segmentation by product type:

Without GalNAc-conjugated

With GalNAc-conjugated

Segmentation by Application:

Genetic Disease

Cancers

Other

This report also splits the market by region:

United States

China

Europe

Other regions:

Japan

South Korea

Southeast Asia

Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

Alnylam

Novartis

Sirnaomics

Ribo Life Science